🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lingfeng Luo

University of South China

ORCID: 0000-0002-0601-0053
Environmental ScienceMedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis”.

Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis

Nature Communications(2024)10.1038/s41467-024-52005-1
N/A
0.823DataRank · unranked
29 citations

Yapei Zhang, Manisha Kumari, Mozhgan Lotfi, Tom Alsaigh, Lingfeng Luo +21 more

Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling

Cardiovascular Research(2021)10.1093/cvr/cvab304
N/A
0DataRank · unranked
18 citations

Yujun Cai, Yishuai Zhang, Chia George Hsu, Vyacheslav A. Korshunov, Xiaochun Long +4 more

The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis

Nature Cardiovascular Research(2022)10.1038/s44161-022-00023-x
N/A
0DataRank · unranked
56 citations

Jianqin Ye, Yoko Kojima, Zhongde Ye, Hua Gao, Sofie Schmid +10 more

Scalable proximal methods for cause-specific hazard modeling with time-varying coefficients

Lifetime Data Analysis(2022)10.1007/s10985-021-09544-2
N/A
0DataRank · unranked
6 citations

Jeremy M. G. Taylor, Andrew F. Brouwer, Lingfeng Luo, Lana X. Garmire, Hui Jiang +2 more

Clustering cancers by shared transcriptional risk reveals novel targets for cancer therapy

Molecular Cancer(2022)10.1186/s12943-022-01592-y
N/A
0DataRank · unranked
4 citations

Richard A. Baylis, Lingfeng Luo, Yoko Kojima, Caitlin Bell, Elsie Ross +3 more

Risk of Cancer After Diagnosis of Cardiovascular Disease

medRxiv(2022)10.1101/2022.08.08.22278548
N/A
0DataRank · unranked
14 citations

Xiudong Lei, Richard A. Baylis, Hua Gao, Lingfeng Luo, Sharon H. Giordano +4 more

Coronary artery disease and prostate cancer share a common genetic risk mediated through Lipoprotein(a)

medRxiv(2022)10.1101/2022.11.08.22282072
N/A
0DataRank · unranked
1 citations

Fudi Wang, Hua Gao, Caitlin Bell, Lingfeng Luo, Kevin T. Nead +5 more

Role of cAMP in Cardiomyocyte Viability: Beneficial or Detrimental?

Circulation Research(2023)10.1161/circresaha.123.322652
N/A
0DataRank · unranked
19 citations

Si Chen, Lingfeng Luo, Sarah Greenly, Hangchuan Shi, Jasmine Jiayuan Xu +2 more

Identifying shared transcriptional risk patterns between atherosclerosis and cancer

iScience(2023)10.1016/j.isci.2023.107513
N/A
0DataRank · unranked
11 citations

Hua Gao, Fudi Wang, Caitlin Bell, Lingfeng Luo, Johan Björkegren +2 more

Spatial Metabolomics and the Vulnerable Atherosclerotic Plaque

Arteriosclerosis Thrombosis and Vascular Biology(2023)10.1161/atvbaha.123.319739
N/A
0DataRank · unranked
4 citations

Nicholas J. Leeper, Lingfeng Luo

Vascular smooth muscle cell plasticity in the tumor microenvironment

Cancer Communications(2024)10.1002/cac2.12635
N/A
0DataRank · unranked
1 citations

Richard A. Baylis, Nicolás López, Wei Feng, Hua Gao, Fudi Wang +8 more

BST2 induces vascular smooth muscle cell plasticity and phenotype switching during cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.10.612298
N/A
0DataRank · unranked
0 citations

Richard A. Baylis, Nicolás López, Wei Feng, Hua Gao, Fudi Wang +8 more

Dynamic changes in chromatin accessibility are associated with the atherogenic transitioning of vascular smooth muscle cells

Cardiovascular Research(2021)10.1093/cvr/cvab347
N/A
0DataRank · unranked
37 citations

Hua Gao, Fudi Wang, Zhongde Ye, Michal Mokrý, Adam W. Turner +14 more

The atherosclerosis–cancer axis: the shared immunotherapeutic potential of CBL inhibition

European Heart Journal(2025)10.1093/eurheartj/ehaf624
N/A
0DataRank · unranked
1 citations

Lingfeng Luo, Nicholas J. Leeper, Kai-Uwe Jarr